Bioequivalence and Bioavailability Forum • Group effects obsolete?

Group effects obsolete? [Two-Stage / GS Designs]

posted by d_labes – Berlin, Germany, 2013-04-18 11:55 (4375 d 03:46 ago) – Posting: # 10431
Views: 45,914

Dear Helmut!

❝ I have seen some FDA code a good while ago:

❝ PROC GLM DATA = DATASET;

❝ CLASS SUB TRT PER SEQ GRP;

❝ MODEL Y = GRP SEQ SEQ*GRP SUBJ(SEQ*GRP) PER(GRP) TRT TRT*GRP /SS3;

❝ RANDOM SUBJ(SEQ*GRP);

❝ TEST H = SEQ GRP E = SUBJ(SEQ*GRP)/HTYPE=3 ETYPE=3;

❝ ESTIMATE 'T VS R' TRT 1 -1;

❝ LSMEANS TRT/STDERR PDIFF CL ALPHA=.1;

❝ RUN;

Yep. Implementation of what is written in the letter.
But IMHO the RANDOM statement is superfluous since it doesn't do anything other than printing a symbolic representation of expected mean squares. If one is really interested in having a random effect for subj(seq*group) Proc MIXED should be used.

❝ Followed by:

❝ ...

Same wording in the letter I have.

But the most interesting part of my letter:
"If all of the following criteria are met, it may not be necessary to test for group effects in the model:
the clinical study takes place at one site;

all study subjects have been recruited from the same enrollment pool;

all of the subjects have similar demographics; and

all enrolled subjects are randomly assigned to treatment groups at study outset
In this latter case, the appropriate statistical model would include only the factors Sequence, Period, Treatment and Subject(nested within sequence."

Can't imagine BE studies where this is not true, except multi-center studies, but these are rare for BE evaluation.
So what? Group effects are a Chimera?

❝ ❝ BTW: Helmut, how had you planned the evaluation of the second stage, if it would be necessary?

❝

❝ Probably too naïvely:

❝ fixed: sequence, treatment, stage, period, group,

❝ group × treatment, stage × treatment

❝ random: subject(sequence × stage)

Too naïvely may be true :-D

—
Regards,

Detlew

Complete thread:

Potvin C in the EU Helmut 2013-04-16 17:40
- Potvin C in the EU ElMaestro 2013-04-17 02:31
  - Potvin C in the EU Helmut 2013-04-17 12:23
    - 2 Groups model FDA d_labes 2013-04-17 13:10
      - 2 Groups model FDA Helmut 2013-04-17 16:37
        
        Group effects obsolete?d_labes 2013-04-18 09:55
        
        Group effects FDA/EMA Helmut 2013-04-19 14:34
        
        Group effects FDA/EMA mittyri 2014-08-21 15:34
        
        Group effects FDA/EMA ElMaestro 2014-08-21 17:31
        
        Group effects EMA mittyri 2014-10-01 11:25
        
        Group effects EMA ElMaestro 2014-10-01 11:31
        Group effects EMA Helmut 2014-10-01 13:24
        
        Group effects EMA VStus 2016-10-06 22:06
        
        Group effects EMA ElMaestro 2016-10-07 12:45
        
        Group effects EMA mittyri 2016-10-07 15:06
        
        Fixed effects model with Group term mittyri 2016-10-09 13:27
        
        Fixed effects model: changing the F, p values mittyri 2016-10-10 18:33
        
        Fixed effects model: changing the F, p values ElMaestro 2016-10-10 20:10
        
        Fixed effects model: changing the F, p values Helmut 2016-10-11 00:17
        Holy War of type III d_labes 2016-10-11 13:17
        
        Significance of Group effect in Russia: why the type III is so 'important' mittyri 2016-10-11 15:07
        
        Fixed effects model: changing the F, p values zizou 2016-10-11 01:06
        
        FDA group model in R mittyri 2016-10-11 13:43
        
        FDA group model in R ElMaestro 2016-10-12 01:07
        FDA group model in R VStus 2016-10-17 15:32
        
        FDA group model in R ElMaestro 2016-10-17 18:58
        
        FDA group model in R VStus 2016-10-20 13:57
        
        Fixed effects model with Group term VStus 2016-10-20 13:54
        
        Group effects FDA/EMA zizou 2016-12-31 02:54
        
        Group effects FDA/EMA Helmut 2017-06-03 14:57
        
        2 Groups model FDA hiren379 2013-08-22 14:32
        
        Homework Helmut 2013-08-23 11:53